BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19848607)

  • 1. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
    Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
    J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.
    Zeremski M; Petrovic LM; Chiriboga L; Brown QB; Yee HT; Kinkhabwala M; Jacobson IM; Dimova R; Markatou M; Talal AH
    Hepatology; 2008 Nov; 48(5):1440-50. PubMed ID: 18798334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection.
    Zeremski M; Hooker G; Shu MA; Winkelstein E; Brown Q; Des Jarlais DC; Tobler LH; Rehermann B; Busch MP; Edlin BR; Talal AH
    J Hepatol; 2011 Sep; 55(3):545-553. PubMed ID: 21256906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C.
    Radmanić L; Šimičić P; Bodulić K; Vince A; Zidovec-Lepej S
    Cytokine; 2024 Apr; 176():156529. PubMed ID: 38335772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL9 Links Skin Inflammation and Fibrosis through CXCR3-Dependent Upregulation of Col1a1 in Fibroblasts.
    Richmond JM; Patel D; Watanabe T; Chen HW; Martyanov V; Werner G; Garg M; Haddadi NS; Refat MA; Mahmoud BH; Wong LD; Dresser K; Deng A; Zhu JL; McAlpine W; Hosler GA; Feghali-Bostwick CA; Whitfield ML; Harris JE; Torok KS; Jacobe HT
    J Invest Dermatol; 2023 Jul; 143(7):1138-1146.e12. PubMed ID: 36708947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL9 and its Receptor CXCR3, an Important Link Between Inflammation and Cardiovascular Risks in RA Patients.
    Shamsi A; Roghani SA; Abdan Z; Soufivand P; Pournazari M; Bahrehmand F; Vafaei A; Salari N; Soroush MG; Taghadosi M
    Inflammation; 2023 Dec; 46(6):2374-2385. PubMed ID: 37542661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases.
    Groover MK; Richmond JM
    F1000Res; 2020; 9():1197. PubMed ID: 33145014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CXCL10-CXCR3 axis plays an important role in Kawasaki disease.
    Hosaka S; Imagawa K; Yano Y; Lin L; Shiono J; Takahashi-Igari M; Hara H; Hayashi D; Imai H; Morita A; Fukushima H; Takada H
    Clin Exp Immunol; 2024 Mar; 216(1):104-111. PubMed ID: 37952216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions.
    Gandolfini I; Mordà B; Martinelli E; Delsante M; Rossi G; Gentile M; Alibrandi S; Salvetti D; Fiaccadori E; Palmisano A; Cravedi P; Maggiore U
    Clin Transplant; 2024 May; 38(5):e15324. PubMed ID: 38678588
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between Circulating Levels of CXCL9 and CXCL10 and Physical Frailty in Older Adults.
    Li J; Hosoyama T; Shigemizu D; Yasuoka M; Kinoshita K; Maeda K; Takemura M; Matsui Y; Arai H; Satake S
    Gerontology; 2024; 70(3):279-289. PubMed ID: 38109864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Transplantation of Cultured Autologous Melanocytes on CXCL9, CXCL10 and CXCL11 Expressions in Vitiligo.
    Xu C; Lei Z; Wang L; Wang H; Hu W; Hairuola H; Kang X
    Indian J Dermatol; 2023; 68(4):486. PubMed ID: 37822411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CXCR3 in fibrotic tissue responses.
    Wells A
    Int J Biochem Cell Biol; 2022 Nov; 152():106311. PubMed ID: 36195287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia/lymphoma (ATLL).
    Rahimzada M; Nahavandi M; Saffari M; Shafaei A; Mosavat A; Ahmadi Gezeldasht S; Ariaee N; Valizadeh N; Rahimi H; Rezaee SA; Derakhshan M
    Mol Biol Rep; 2023 Sep; 50(9):7479-7487. PubMed ID: 37480512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and functional roles of chemokines in liver diseases.
    Cao S; Liu M; Sehrawat TS; Shah VH
    Nat Rev Gastroenterol Hepatol; 2021 Sep; 18(9):630-647. PubMed ID: 33976393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C.
    Khera T; Du Y; Todt D; Deterding K; Strunz B; Hardtke S; Aregay A; Port K; Hardtke-Wolenski M; Steinmann E; Björkström NK; Manns MP; Hengst J; Cornberg M; Wedemeyer H
    J Infect Dis; 2022 Aug; 226(3):441-452. PubMed ID: 33517457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Inflammation in Virus Pathogenesis during Pregnancy.
    Chudnovets A; Liu J; Narasimhan H; Liu Y; Burd I
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma-induced protein 10 (IP-10) and cardiovascular disease in African Americans.
    Leavitt C; Zakai NA; Auer P; Cushman M; Lange EM; Levitan EB; Olson N; Thornton TA; Tracy RP; Wilson JG; Lange LA; Reiner AP; Raffield LM
    PLoS One; 2020; 15(4):e0231013. PubMed ID: 32240245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy.
    Balagopal A; Smeaton LM; Quinn J; Venuto CS; Morse GD; Vu V; Alston-Smith B; Cohen DE; Santana-Bagur JL; Anthony DD; Sulkowski MS; Wyles DL; Talal AH
    J Infect Dis; 2020 Jul; 222(4):601-610. PubMed ID: 32201883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?
    Ferrari SM; Fallahi P; Ruffilli I; Elia G; Ragusa F; Paparo SR; Patrizio A; Mazzi V; Colaci M; Giuggioli D; Ferri C; Antonelli A
    J Immunol Res; 2019; 2019():5878960. PubMed ID: 31485460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.